These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


630 related items for PubMed ID: 17568450

  • 21. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro.
    Nakamura A, Ly C, Cipetić M, Sims NA, Vieusseux J, Kartsogiannis V, Bouralexis S, Saleh H, Zhou H, Price JT, Martin TJ, Ng KW, Gillespie MT, Quinn JM.
    Bone; 2007 Feb; 40(2):305-15. PubMed ID: 17049328
    [Abstract] [Full Text] [Related]

  • 22. Osteogenic effects of bone-morphogenetic-protein-2 plasmid gene transfer.
    Seol YJ, Kim KH, Park YJ, Lee YM, Ku Y, Rhyu IC, Lee SJ, Han SB, Chung CP.
    Biotechnol Appl Biochem; 2008 Jan; 49(Pt 1):85-96. PubMed ID: 17608624
    [Abstract] [Full Text] [Related]

  • 23. Thyroid hormone suppresses the differentiation of osteoprogenitor cells to osteoblasts, but enhances functional activities of mature osteoblasts in cultured rat calvaria cells.
    Ohishi K, Ishida H, Nagata T, Yamauchi N, Tsurumi C, Nishikawa S, Wakano Y.
    J Cell Physiol; 1994 Dec; 161(3):544-52. PubMed ID: 7962135
    [Abstract] [Full Text] [Related]

  • 24. Three-dimensional composites manufactured with human mesenchymal cambial layer precursor cells as an alternative for sinus floor augmentation: an in vitro study.
    Turhani D, Watzinger E, Weissenböck M, Yerit K, Cvikl B, Thurnher D, Ewers R.
    Clin Oral Implants Res; 2005 Aug; 16(4):417-24. PubMed ID: 16117765
    [Abstract] [Full Text] [Related]

  • 25. Osteoblast differentiation in vitro and in vivo promoted by Osterix.
    Fu H, Doll B, McNelis T, Hollinger JO.
    J Biomed Mater Res A; 2007 Dec 01; 83(3):770-8. PubMed ID: 17559111
    [Abstract] [Full Text] [Related]

  • 26. Cystatin C stimulates the differentiation of mouse osteoblastic cells and bone formation.
    Danjo A, Yamaza T, Kido MA, Shimohira D, Tsukuba T, Kagiya T, Yamashita Y, Nishijima K, Masuko S, Goto M, Tanaka T.
    Biochem Biophys Res Commun; 2007 Aug 17; 360(1):199-204. PubMed ID: 17592728
    [Abstract] [Full Text] [Related]

  • 27. Effect of ipriflavone on expression of markers characteristic of the osteoblast phenotype in rat bone marrow stromal cell culture.
    Notoya K, Yoshida K, Tsukuda R, Taketomi S.
    J Bone Miner Res; 1994 Mar 17; 9(3):395-400. PubMed ID: 8191934
    [Abstract] [Full Text] [Related]

  • 28. ApoE gene deficiency enhances the reduction of bone formation induced by a high-fat diet through the stimulation of p53-mediated apoptosis in osteoblastic cells.
    Hirasawa H, Tanaka S, Sakai A, Tsutsui M, Shimokawa H, Miyata H, Moriwaki S, Niida S, Ito M, Nakamura T.
    J Bone Miner Res; 2007 Jul 17; 22(7):1020-30. PubMed ID: 17388726
    [Abstract] [Full Text] [Related]

  • 29. Guided bone regeneration in pig calvarial bone defects using autologous mesenchymal stem/progenitor cells - a comparison of different tissue sources.
    Stockmann P, Park J, von Wilmowsky C, Nkenke E, Felszeghy E, Dehner JF, Schmitt C, Tudor C, Schlegel KA.
    J Craniomaxillofac Surg; 2012 Jun 17; 40(4):310-20. PubMed ID: 21723141
    [Abstract] [Full Text] [Related]

  • 30. Sulfuretin promotes osteoblastic differentiation in primary cultured osteoblasts and in vivo bone healing.
    Auh QS, Park KR, Yun HM, Lim HC, Kim GH, Lee DS, Kim YC, Oh H, Kim EC.
    Oncotarget; 2016 Nov 29; 7(48):78320-78330. PubMed ID: 27713171
    [Abstract] [Full Text] [Related]

  • 31. Use of isolated mature osteoblasts in abundance acts as desired-shaped bone regeneration in combination with a modified poly-DL-lactic-co-glycolic acid (PLGA)-collagen sponge.
    Ochi K, Chen G, Ushida T, Gojo S, Segawa K, Tai H, Ueno K, Ohkawa H, Mori T, Yamaguchi A, Toyama Y, Hata J, Umezawa A.
    J Cell Physiol; 2003 Jan 29; 194(1):45-53. PubMed ID: 12447988
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Sanguis Draconis resin stimulates osteoblast alkaline phosphatase activity and mineralization in MC3T3-E1 cells.
    Wang W, Olson D, Cheng B, Guo X, Wang K.
    J Ethnopharmacol; 2012 Jun 26; 142(1):168-74. PubMed ID: 22543168
    [Abstract] [Full Text] [Related]

  • 34. Effect of combined application of bFGF and inorganic polyphosphate on bioactivities of osteoblasts and initial bone regeneration.
    Yuan Q, Kubo T, Doi K, Morita K, Takeshita R, Katoh S, Shiba T, Gong P, Akagawa Y.
    Acta Biomater; 2009 Jun 26; 5(5):1716-24. PubMed ID: 19251495
    [Abstract] [Full Text] [Related]

  • 35. Pore size regulates cell and tissue interactions with PLGA-CaP scaffolds used for bone engineering.
    Sicchieri LG, Crippa GE, de Oliveira PT, Beloti MM, Rosa AL.
    J Tissue Eng Regen Med; 2012 Feb 26; 6(2):155-62. PubMed ID: 21446054
    [Abstract] [Full Text] [Related]

  • 36. Drynariae Rhizoma promotes osteoblast differentiation and mineralization in MC3T3-E1 cells through regulation of bone morphogenetic protein-2, alkaline phosphatase, type I collagen and collagenase-1.
    Jeong JC, Lee JW, Yoon CH, Kim HM, Kim CH.
    Toxicol In Vitro; 2004 Dec 26; 18(6):829-34. PubMed ID: 15465649
    [Abstract] [Full Text] [Related]

  • 37. Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells.
    von Knoch F, Jaquiery C, Kowalsky M, Schaeren S, Alabre C, Martin I, Rubash HE, Shanbhag AS.
    Biomaterials; 2005 Dec 26; 26(34):6941-9. PubMed ID: 16009417
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Osteogenic differentiation of human adipose tissue-derived stromal cells (hASCs) in a porous three-dimensional scaffold.
    Lee JH, Rhie JW, Oh DY, Ahn ST.
    Biochem Biophys Res Commun; 2008 Jun 06; 370(3):456-60. PubMed ID: 18395007
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 32.